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Abstract
Emerging Non-communicable diseases burden move United Nation to call for 25% reduction by 2025 in premature
mortality from non-communicable diseases (NCDs). The World Health Organization (WHO) developed global action
plan for prevention and control NCDs, but the countries’ contexts, priorities, and health care system might be
different. Therefore, WHO expects from countries to meet national commitments to achieve the 25 by 25 goal
through adapted targets and action plan.
In this regards, sustainable high-level political statement plays a key role in rules and regulation support, and
multi-sectoral collaborations to NCDs’ prevention and control by considering the sustainable development goals
and universal health coverage factors.
Therefore, Iran established the national authority’s structure as Iranian Non Communicable Diseases Committee
(INCDC) and developed NCDs’ national action plan through multi-sectoral approach and collaboration researchers
and policy makers. Translation Iran’s expertise could be benefit to mobilizing leadership in other countries for
practical action to save the millions of peoples.
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Background
Alarming increase of premature mortality from non-
communicable diseases across the world considered by
Global action plan on NCDs and Sustainable Develop-
ment Goals [1–3]. Also, the High-Level Meeting on
NCDs in the United Nations emphasized on the need of
all government policy response to this dramatic problem
[4]. NCDs were responsible to more than 38 million
deaths in the world and annually, non-communicable
diseases responsible for 16 million premature death [5].
This staggering toll of non-communicable diseases and
premature mortality leads policy makers to pay attention
and instigate action across the globe [6].
Evidences indicate that, Iran threatened by NCDs too
[7–10]. In Iran, during the recent decades, the socio-
economic development and the successful function of
Primary Health Care (PHC) bring out health promotion,
child, and maternal mortality decrease [11]. In addition,
life expectancy increased from 66 to 78 years in period
of 1990 to 2013.
Following these progresses in health situation of
Iranians, a remarkable revolution occurred in the health
status of the country especially in the field of communic-
able diseases. Nevertheless, non-communicable diseases
remained as the great health problem in Iran. In 2013,
236 thousand deaths in Iran occurred due to NCDs and
there was 14.5% increase of NCDs’ death during two
past decades [12]. At the same time, mental disorders,
substance abuse and traffic injuries were cause of 15821* Correspondence: larijanib1340@gmail.com
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deaths. It is remarkable, 82.2% of NCDs’ death is due to
cardiovascular diseases, cancers, chronic pulmonary dis-
eases, and diabetes and these are top ranks of cause of
death in the country [12]. In Iran, dietary risks are the
first line of NCDs’ risk factors and metabolic risk factors
stand at second position. Tobacco smoke, air pollution,
low physical activity, and alcohol and drug use are the
next related risk factors, respectively [12].
In 2013, NCDs led to 7 million years lived with
disability (YLD) in Iran [13]. It is considerable, NCDs
accompanied with economical burden because of
productivity reduction and diverting resources from
productive purposes to NCDs treatment. Because of,
the poor population struggled with health expend-
iture and living costs, they have been suffered from
economic stress more than other people [12, 14]. It is
remarkable; the first cause of catastrophic health ex-
penditures is NCDs and this problem reinforce soci-
etal inequities [6, 15].
Non-communicable diseases ignored during the fram-
ing of the Millennium Development Goals in 2000, but
clarification of the reality leads the policymakers to pay
attention to it. The United Nations and the World
Health Organization (WHO) have called for a 25% re-
duction by 2025 in mortality from non-communicable
diseases among persons between 30 and 70 years of
age, in comparison with mortality in 2010, adopting the
slogan “25 by 25” [4].
Universal health coverage (UHC) as a critical compo-
nent of sustainable development reduces poverty and
social inequities through financial risk protection. It is
important; the Key elements of the right to health are
availability, accessibility, acceptability, quality [16].
By considering these rights and responding to signifi-
cant burden of NCDs, the World Health Organization
(WHO) developed the global action plan for the pre-
vention and control of NCDs (2013–2020) which con-
tain 9 targets by considering four main risk factors;
including tobacco use, an unhealthy diet, lack of phys-
ical activity and harmful alcohol use. These behavioral
risk factors are associated with four main disease clus-
ters mentioned above [17]. As many NCDs’ death and
disability are preventable by appropriate interventions,
this action plan provides policy options for countries to
strengthen them to reduce premature deaths from
NCDs by 25% by 2025 [18].
The WHO has messaged; the countries could shift from
political commitment to effective action by prioritizing
affordable interventions. This organization emphasized on
the need of all countries to set national NCDs targets and
responsible to attain them [19, 20].
The aim of this paper is to present the emerging Iranian
architecture for NCDs’ prevention and control and create
NCDs’ national action plan to move forward.
Response to emerging NCDs’ epidemic
Political commitment
Mandate with the task of developing a national action
plan for NCDs’ prevention and control was the oppor-
tunity for Iran to commitment 25 by 25 NCDs goal [21].
In context of national action plans, we could arrange
feasible, scalable, affordable, and cost effective interven-
tions to reduce NCDs’ mortality and morbidity and attain
to the most efficient and equitable health system [22, 23].
Success in response to NCDs crisis depends on strong
and effective leadership in high-level political statement
[24]. In this way, health policies support regulatory, le-
gislative and inter-sectoral collaborations to address
equity and reduction NCDs’ outcomes.
Establishment sustainable national leadership
Ministry of Health and Medical Education (MOHME) of
Iran as strong and effective leadership in high-level polit-
ical statement established Iranian non-communicable dis-
eases committee (INCDC) with the aim of comprehensive
policy making, planning, and monitoring of all activities in
the area of non-communicable diseases in Iran.
As shown in Fig. 1, INCDC set up by inter and intra-
sectoral collaboration. The presented flow demonstrates
the relationships between inter and intra-sectoral parts.
The body of INCDC contains ministry of health deputies,
supreme council of health and food security and related
to medical sciences universities.
Iranian non-communicable diseases committee has
nine sub-committees according to various aspects of
prevention and controls NCDs and their risk factors and
national targets (Fig. 1).
A stepwise move toward action
First step: setting clear and appropriate targets in national
level
Planning is one of the key steps for responding to NCDs’
dramatic epidemic [25]. “National Action Plan for Pre-
vention and Control of Non-Communicable Diseases and
the related risk factors in Iran, 2015-2025” was devel-
oped by considering our country’s priorities, National
and Sub-national Burden of Diseases, and WHO global
targets [1, 26–29].
The national action plan for NCDs Prevention and
Control in Iran including 9 targets based on global action
plan for NCDs and 4 special targets regarding trans fatty
acid, traffic injuries, drug abuse, and mental diseases.
Among nine global targets on prevention and control
NCDs, target 3 and target 8 adapted for our country
situation. According to WHO report, Prevalence of
insufficient physical activity in Iranian adult was 24.1%
among men and 42.9% among women [30, 31]. The
3th target of NCDs global action plan set to reduce
physical inactivity by 10% by 2025. According to our
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country situation, we considered 20% reduction of
physical inactivity.
In addition, the eighth target of global action plan set
to receiving drug therapy and counseling to prevent
heart attacks and strokes by 50% of eligible people. But
we accelerate this desired measure to 70% because of
access to medicines plays a vital role in universal health
coverage goals achievement and already we stand up
good point [32]. It is remarkable, the other targets were
appropriate for Iran by considering our conditions and
situation analysis.
In addition to glossary WHO targets, United Nation
proposed Sustainable Development Goals (SDGs). The
third sustainable development goal focused on health
and considered UHC as a mean of health equity. It is
needed to effective attention to non-communicable
diseases [33].
By considering burden of diseases in Iran, targets 10
to 13 set for our country (Table 1).
In Table 1, 13 national targets of Iran and their rela-
tionship with Sustainable Development Goals presented
[2, 34–36]. UHC and health system goals are related
to all NCDs targets and all of them are in the way of
poverty reduction.
Second step: mobilization, inter & intra-sectoral collaboration
and developing national action plan for NCDs prevention
and control in Iran
In developing NCDs’ national action plan of Iran, inter
and intra-sectoral collaboration was considered. INCDC
initiated dialogue with health system sectors and the
other ministries to response NCDs’ prevention and control.
This multi-sectoral procedure and collaborating approach
led to develop the national document based on recom-
mended WHO framework contain four areas of govern-
ance, prevention and reduction of risk factors, health care,
and surveillance, monitoring and evaluation.
Through collaborative planning, the time bounded
national action plan was prepared based on clear policies
with clarified targets, strategies and activities and deter-
mined stakeholders, desired outcome, evaluation criteria,
and resources [34].
Third step: enlist the support of national and international
policy makers
Prepared NCDs’ action plan supported by President, par-
liament speaker, Vice President, Head of Management
and Planning Organization, Head of Environmental Pro-
tection Organization, Head of Islamic Republic of Iran
Fig. 1 The inter and intra- sectoral collaboration of Iranian Non Communicable Diseases Committee
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Broadcasting, and nine Ministers in the government
Cabinet. This holistic political support and responsibility
might be unique in the region. It is remarkable, supreme
council of health, chaired by president approved “Na-
tional Action Plan for Non-Communicable Diseases
Prevention and Control in Iran” and minister of health
directed medical sciences universities to implement it in
order to health promotion of community as the main
stakeholder through sub-national NCDs’ committee.
Forth step: participation of sub-national policy makers
Iran has 61 Medical Sciences University which their
health services covered all provinces of Iran. Integration
of medical education and health in the Ministry of
Health and Medical Education create appropriate atmos-
phere for strengthening the health care system in Iran
[37, 38]. Towards realizing NCDs’ prevention and control
targets, INCDC invited Medical Sciences Universities’
chancellors as the main authorities in sub-national health
sectors. They could be directed provincial committees
through collaborative arrangements to address local prior-
ities and should be committed to multi-sectoral approach.
This approach is essential among planning, implemen-
tation and accountability as key stages of response to
NCDs’ problem [25].
To accelerate country response to non-communicable
diseases prevention and control, policy makers could
follow these strategies to strengthen governance, risk
reduction, health care, and surveillance. Generating
national and sub-national information and monitor the
trends of NCDs and their risk factors, establishing health
promotion programs across the life course through pri-
mary health care system and universal health coverage
components, and tackling issues through multi-sectoral
approach are critical strategies be suggested.
Conclusion
The structured and stepwise approach of Iran towards
NCDs prevention and control bring out a proposed
way in the mixture of challenges and successes. Our ex-
periences indicate that the Strong leadership needed to
pass the way of fighting against NCDs. We emphasized
on this principle; the successful response to NCDs need
to multi-sectoral approach, the engagement of all health
sectors and related stakeholders including other minis-
tries and organizations [34].
Iranian Non-communicable Diseases Committee
(INCDC) is an appropriate model in supreme level for
mega coordination [39, 40]. According to NCDs’ pro-
gress monitor report of WHO, Iran stand up the first
rank in Eastern Mediterranean region and could be
share lesson learned to other countries [41].
Resource mobilization, technical allocation, health work-
force development and health care quality improvement
are essential for action plan implementation. Poor lead-
ership, change management, financial constraints, poor
health infrastructure, inadequate qualified human re-
sources, poor information and communication, poor coord-
ination and resistance of some organizations might be lead
to implementation collapse [42, 43]. But, clear vision and
mission, stability of political factors, local authorities sup-
port, financial resources management, motivating private
sector and emerging economic powers, Internal monitoring
and evaluation, strengthening supportive supervision and
increasing motivation through recognition of best practice
could be benefit for successful implementation.
Overcoming possible barriers in action plan implemen-
tations, scaling up interventions and health management
in various levels of health services leads to reduce years of
life lost (YLL) and YLD due to NCDs and finally benefit
for health equity and financial protection [44].
President, parliament, supreme council of health mem-
bers and cabinet ministers’ support and collaboration with
other ministries and organizations were unique experience
in the region. Access to efficient epidemiological informa-
tion, explicit views of national policy makers in various
domains of public health, treatment, food and medicine,
education, and research. Partnership of policy and deci-
sion makers, scientist, researchers and health experts in
national action plan development, establishment national
sub committees guided by national authorities and struc-
turing the provincial committees as the frontline of health
services were our strengths.
Of course, we faced to some challenges in resource
mobilization. Despite our long-term goals, INCDC was not
finance by specific and sufficient budget. In addition, lack
of private health sector and Nongovernmental organiza-
tions’ collaboration was the other limitation could be con-
sidered in the way forward. The other important challenge
was incompleteness and misclassification reporting of cause
of death that addressed by National and Sub-national Bur-
den of Diseases Study (NASBOD) and now, we have com-
prehensive atlas of death in by cause in various levels [26].
Finally, Similar to other experience, we suggest inte-
gration of NCDs’ prevention and control in primary
health care, enforce appropriate interventions led by
provincial committee, technical use of existing infra-
structure and human resources, innovative resource
mobilization such as funding through nongovernmen-
tal resource, provide progress monitoring system and
ensure accountability from the involved sectors, and
actions to accelerate progress [20, 36, 45].
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